The DOI matches its Crossref record; 147 of the 150 references it cites were found in a registry or an index.
Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Abstract
Congenital adrenal hyperplasias (CAH) are inherited defects of cortisol biosynthesis. More than 90% of CAH are caused by 21-hydroxylase deficiency (21-OHD), found in 1:10 000 to 1:15 000 live births. Females with 'classical' 21-OHD, being exposed to excess androgens prenatally, are born with virilized external genitalia. Potentially lethal adrenal insufficiency is characteristic of two-thirds to three-quarters of patients with the classical salt wasting (SW) form of 21-OHD. Non-SW 21-OHD may be diagnosed on genital ambiguity in affected females, and/or later on the occurrence of androgen excess in both sexes. Non-classical 21-OHD, detected in > or =1:100 of certain populations, may present as precocious pubarche in children or polycystic ovarian syndrome in young women. 21-OHD is caused by mutations in the CYP21 gene encoding the steroid 21-hydroxylase enzyme. More than 90% of these mutations result from intergenic recombination between CYP21 and the closely linked CYP21P pseudogene. The degree to which each mutation compromises enzymatic activity is strongly correlated with the clinical severity of the disorder. This close association between genotype and phenotype makes it possible to predict clinical outcome in affected subjects. The risk of SW and prenatal virilization can be estimated, and overtreatment can be avoided in mildly affected cases. Glucocorticoid and mineralocorticoid replacement therapies are the mainstays of treatment, but additional therapies are being developed. A first trimester prenatal diagnosis should be proposed in families in whom molecular studies have been performed previously. The state of heterozygotism can be predicted by hormonal testing and confirmed by molecular studies. Prenatal diagnosis by direct mutation detection in previously genotyped families permits prenatal treatment of affected females in order to avoid or minimize genital virilization. Neonatal screening by hormonal methods identifies affected children before SW crises develop, reducing mortality in this disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, 17-hydroxypregnenolone also accumulates and is readily converted to DHEA, and subsequently to androstenedione and testosterone, resulting in severe prenatal virilization of female fetuses (350 -354).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [354]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“21-Hydroxylase deficiency, caused by mutations in P450c21, is the most common form of CAH and one of the most common inborn errors of metabolism.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [354]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
White, P. C. (2000) · Endocrine Reviews · doi:10.1210/er.21.3.245 · Cited by 877
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data
NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-320 · Cited by 624
Masculinized Finger Length Patterns in Human Males and Females with Congenital Adrenal Hyperplasia
Brown, W. M., Hines, M., Fane, B. A., & Breedlove, S. M. (2002) · Hormones and Behavior · doi:10.1006/hbeh.2002.1830 · Cited by 499
Vogeser, M., Zachoval, R., Felbinger, T. W., Jacob, K., Radetti, G., Bona, G., Corrias, A., Cappa, M., DeSanctis, V., Lauriola, S., et al. (2002) · Hormone Research in Paediatrics · doi:10.1159/000065490 · Cited by 452
Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B
Bristow, J., Tee, M., Gitelman, S., Mellon, S., & Miller, W. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.265 · Cited by 302
Creighton, S., Minto, C. L., & Steele, S. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05343-0 · Cited by 297
Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency.
Merke, D. P., Chrousos, G. P., Eisenhofer, G., Weise, M., Keil, M. F., Rogol, A. D., Van Wyk, J. J., & Bornstein, S. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431903 · Cited by 266
New, M. I., Carlson, A., Obeid, J., Marshall, I., Cabrera, M. S., Goseco, A., Lin-Su, K., Putnam, A. S., Wei, J. Q., & Wilson, R. C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8072 · Cited by 263
Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency
David, M., & Forest, M. G. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80310-8 · Cited by 253
Self-citation
Research works printed but not linked: 1
- [49]49. Guidollet-Tardy V (2002) Le de ´ficit en 21-hydroxylase Mise au point de l'exploration mole ´culaire de 1538 patients et 188 he ´te ´rozygotes; Corre ´- lations ge ´notype-phe ´notype. PhD Thesis, University Lyon I, 256pp.
Cited by
Sorted by citations
Items 101–200 of 200
[Peripheral precocious puberty].
Krysiak, R. G., Marek, B., & Okopień, B. (2009) · PubMed · Cited by 6
Eunice, M., & Ammini, A. C. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.111596 · Cited by 6
“[3,4] Later, other groups also reported a reduction in the degree of virilization in affected female fetuses with DEX treatment.[5,6] The treatment has been proven to be highly effective for the reduction of genital masculinization in 46, XX fetuses, if begun by the 8th week postconception and used consistently throug…”
Blaskó, B., Bánlaki, Z., Gyapay, G., Pozsonyi, É., Sasvári‐Székely, M., Rajczy, K., Füst, G., & Szilágyi, Á. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.033 · Cited by 6
Denham, S. G., Just, G., Kyle, C. J., Richardson, J., Lee, P. J., Simpson, J., Gifford, R. M., Andrew, R., Reynolds, R. M., & Homer, N. Z. M. (2020) · Preprints.org · doi:10.20944/preprints202011.0551.v1 · Cited by 5
“Assessing the steroidogenic cascade is used in diagnosis and monitoring of a number of endocrine disorders e.g. congenital adrenal hyperplasia (CAH) [1, 2, 3, 4, 5], Cushing’s [6,7] syndrome, Addison’s disease [8, 9], adrenal cancers [10,11,12,13] and polycystic ovary syndrome (PCOS) [14, 15, 16].”
BackgroundSalt-Wasting Form of Congenital Adrenal Hyperplasia: A Case Report
Twayana, A. R., Sunuwar, N., Deo, S., Tariq, W. B., Anjum, A., Rayamajhi, S., & Shrestha, B. (2022) · Cureus · doi:10.7759/cureus.27807 · Cited by 6
“Both are caused by enzymes that are only produced in the adrenal glands [3].”
BackgroundInfluential21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia
Shaw, A. (2010) · Neonatal Network The Journal of Neonatal Nursing · doi:10.1891/0730-0832.29.3.191 · Cited by 5
Kim, S., Jung, H., Chung, B. C., & Choi, M. H. (2011) · Mass spectrometry letters · doi:10.5478/msl.2011.2.3.069 · Cited by 5
Genotype-phenotype correlation in patients with 21-hydroxylase deficiency
Tang, P., Zhang, J., Peng, S., Wang, Y., Li, H., Wang, Z., Zhang, Y., Huang, Y., Xu, J., Zhang, D., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1095719 · Cited by 7
“Classic SV is characterized by prenatal virilization in females and virilization in both sexes without salt wasting (4).”
BackgroundVieira, A., Paiva, S., Baptista, C. F., Ruas, L., Silva, J., Gonçalves, J., Carrilho, F., & Carvalheiro, M. C. (2011) · Acta Médica Portuguesa · doi:10.20344/amp.338 · Cited by 5
Völkl, T. M. K., Rauh, M., Schöfl, C., & Dörr, H. G. (2011) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2011.05.001 · Cited by 5
“The clinical and laboratory picture of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH) is caused by glucocorticoid deficiency with or without involvement of the mineralocorticoid system with a consecutively increased stimulation of the hypothalamo-pituitary (CRH–ACTH) axis and increased productio…”
BackgroundGuillén, L. S., Paracchi, M. V. D. C., & Ezquieta, B. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2009.06.008 · Cited by 5
Untreated congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Tahirović, H. F., Toromanović, A., Grubić, M., Grubić, Z., & Dumic, K. K. (2008) · European Journal of Pediatrics · doi:10.1007/s00431-008-0847-2 · Cited by 5
“More than 90% of CAH are caused by 21-hydroxylase deficiency (21-OHD), found in 1:10,000 to 1:15,000 live births [1].”
BackgroundPediatric Urological Emergencies
Lambert, S. M. (2012) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2012.05.014 · Cited by 4
CHANDRAN, S. R., & Loh, L. M. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1490399 · Cited by 4
“The treatment also has been found to be relatively safe for both the fetus and the mother in the short-term [11,12].”
BackgroundVerma, P., Sharma, S., Kaur, S., Rohilla, L., Malhi, P., & Dayal, D. (2023) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0559 · Cited by 4
Congenital adrenal hyperplasia causing clitoromegaly.
Mustafa, R., Hashmi, H. A., & Ullah, S. (2008) · PubMed · Cited by 4
Du, Y., Tian, H., Li, J., Gao, J., Liu, W., Lu, F., Qin, H., & Mao, S. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c05982 · Cited by 3
Sanctis, V. D., Clemente, S., Gallotta, M. C., Filati, G., Fiscina, B., Marsciani, A., PIACENTINI, G. L., Timoncini, G., Reggiani, L., Zucchini, A., et al. (2012) · PubMed · Cited by 3
Assessing the risk of having a child with classic 21-hydroxylase deficiency: a new paradigm
Ilany, J., & Cohen, O. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.04.007 · Cited by 3
de Armas, G. G. (2011) · InTech eBooks · doi:10.5772/16944 · Cited by 3
Current perspective and scope of fetal therapy: part 2
Sharma, D., & Tsibizova, V. I. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1839881 · Cited by 4
“and was used in compliance throughout pregnancy [51,54,63].”
MethodGenotypic spectrum of 21-hydroxylase deficiency in an endogamous population
Mahmoud, R. A. A., Amr, N. H., Toaima, N. N., Kamal, T. M., & Elsedfy, H. H. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01648-8 · Cited by 3
“Thus, the prevalence of classic and NC forms as well as their mutation pattern varies among different ethnic populations [10].”
BackgroundDreger, A., Feder, E. K., & Lindemann, H. (2010) · The American Journal of Bioethics · doi:10.1080/15265161.2010.499584 · Cited by 3
“…therapy and, hence, must only be done with fully informed consent in controlled prospective trials approved by human experimentation committees” (Forest 2004, 479) Astoundingly, McCullough and colleagues quote the Joint LWPES/ESPE statement to show that “there is substantial difference of…”
BackgroundSalim, M., Al-Mayoof, A. F., Joda, A. E., & Almushhadany, O. I. (2022) · Mustansiriya Medical Journal · doi:10.4103/mj.mj_32_21 · Cited by 2
Differential Diagnosis of Tumors in the Adrenogenital Syndrome
Nistal, M., González‐Peramato, P., & Serrano, Á. (2017) · Springer eBooks · doi:10.1007/978-3-319-49364-0_7 · Cited by 2
Zurita‐Cruz, J. N., Villasís-Keever, M. Á., Damasio‐Santana, L., Apolinar, L. M., Ferrusca-Ceja, R., Nishimura‐Meguro, E., Rivera-Hernández, A. D. J., & Garrido-Magaña, E. P. (2018) · Gaceta Médica de México · doi:10.24875/gmm.18002952 · Cited by 2
la Paz, E. M. C., Abaya, E. C., Silao, C. L. T., Capistrano-Estrada, S. B., & Padilla, C. D. (2009) · Acta Medica Philippina · doi:10.47895/amp.v43i2.2497 · Cited by 2
Diamond, D. A., & Yu, R. N. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00133-x · Cited by 2
Congenital Adrenal Hyperplasia
Levine, L. S., Oberfield, S. E., & Antler, L. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-499-5_12 · Cited by 2
Buske, B. (2006) · Open Repository and Bibliography (University of Liège) · Cited by 2
New Horizons: Molecular Basis and Novel Therapeutics in Congenital Adrenal Hyperplasia
Prasad, R., & Deswal, S. (2022) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-021-01020-w · Cited by 2
“However, the short half-life of hydrocortisone minimizes growth suppression along with other side effects of longer acting, more potent glucocorticoids such as prednisone and dexamethasone [7].”
BackgroundAnti-mullerian hormone serum level in patients with congenital adrenal hyperplasia
Ziora, K. T., Borawska-Dziadek, E., Oświęcimska, J. M., Świętochowska, E., Ostrowska, Z., Kajdaniuk, D., Wikiera, B., Bieniasz, J., Noczyńska, A., Bursa, J., et al. (2016) · Pediatric Endocrinology · doi:10.18544/ep-01.15.03.1647 · Cited by 1
Integrated mapping resolves pathogenicity of 11 CYP21A2 variants in congenital adrenal hyperplasia
Xu, Y., Matveeva, A., Jørgensen, F. S., & Pandey, A. V. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag127 · Cited by 1
“It typically occurs when alleles possessing 20% to 50% of wild-type (WT) activity in vitro are paired with a severe mutation and presents later in childhood or adulthood with symptoms of hyperandrogenism, such as premature pubarche, hirsutism, and infertility [8, 9].”
Urologic Emergencies in Children: Special Considerations
Cook, A., & Koury, A. E. (2007) · Springer eBooks · doi:10.1007/978-3-540-48605-3_8 · Cited by 1
Stoeva, I., Kostova, A., Moskova, M., Тодорова, А., Todorov, T., Kirov, A., & Aroyo, A. (2014) · Scripta Scientifica Medica · doi:10.14748/ssm.v46i4.1014 · Cited by 1
A case of congenital adrenal hyperplasia presenting as adrenal incidentaloma
Choi, M.-J., Kim, B. H., Sohn, K. M., Yang, H. N., Ryu, O. H., Choi, M. G., & Yoo, H. J. (2009) · The Korean Journal of Internal Medicine · Cited by 1
Management of Pregnancy in a Patient with Nonclassical Congenital Adrenal Hyperplasia
Miller, A. J., & Malek, R. (2017) · AACE Clinical Case Reports · doi:10.4158/ep171958.cr · Cited by 1
Liu, J., Zhang, X., Zhang, H., Li, F., Xu, J., Guan, Q., & Xu, C. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8391 · Cited by 1
“Steroid 21‑hydroxylase deficiency (21‑OHD), the most common variant of CAH, accounts for ~90% of CAH cases (2,3).”
Genetic Defects of Female Sexual Differentiation
Cools, M., der Grinten, H. L. C., Baere, E. D., Callens, N., & Dessens, A. B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00068-7 · Cited by 1
An 11-year-old girl with genital ambiguity: a case of non-classical congenital adrenal hyperplasia
Monni, A. F., Sobhan, R., Pathan, M. F., Afsana, F., & Amin, F. (2020) · BIRDEM Medical Journal · doi:10.3329/birdem.v10i3.48717 · Cited by 1
Bourcigaux, N., & Christin‐Maître, S. (2007) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(07)41281-9 · Cited by 1
Yu, J., Lu, S., Fang, L., Kakongoma, N., & Hu, W. (2023) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2023.12.008 · Cited by 1
The History of Prenatal Diagnosis of Congenital Adrenal Hyperplasia
Mancenido, D., & New, M. I. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00004-1 · Cited by 1
Sami, S. A., Moffett, B. S., Karlsten, M., Cabrera, A. G., Price, J. F., Dreyer, W. J., Denfield, S. W., & Jeewa, A. (2015) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-20.5.393 · Cited by 1
Feminizing genitoplasty in congenital adrenal hyperplasia
Shoeir, H. M., Wali, M. E.-G., AbdelHamid, T. B., & El-Zeiny, M. (2012) · Annals of Pediatric Surgery · doi:10.1097/01.xps.0000418527.14707.bc · Cited by 1
Halder, A., & Gupta, R. K. (2008) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
CONGENITAL ADRENAL HYPERPLASIA: PRESENTATION IN A MALE INFANT
Sunil, B., Sahana, G., Adarsh, E., Purushotham, D. R., & Rajanish, K. V. (2013) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/1597 · Cited by 1
“steroids and fluid replacement is the key for the successful diagnosis and management of adrenal crises due to classic CAH [3].”
InfluentialMao, X., Jing, M., & Tian, H.-Y. (2016) · PubMed Central · doi:10.7499/j.issn.1008-8830.2016.08.005 · Cited by 1
Mutasi Gen CYP21 dan Manifestasi Klinis pada Hiperplasia Adrenal Kongenital
Rahmartani, L. D., Batubara, J. R. L., Handryastuti, S., & Prayitno, L. (2016) · Sari Pediatri · doi:10.14238/sp18.1.2016.27-33 · Cited by 1
Congenital Adrenal Hyperplasia – The Main Effect of 21-Hydroxylase Deficiency
Carvalho, B., Carvalho, F., & Carvalho, D. M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.107092 · Cited by 1
Fritz, R. (2015) · Human Biology · Cited by 1
Bento, L. R., Ramos, C. C. A., Gonçalves, E. M., de Mello, M. P., Baptista, M. T. M., de Lemos‐Marini, S. H. V., & Guerra‐Júnior, G. (2007) · Revista Paulista de Pediatria · doi:10.1590/s0103-05822007000300002 · Cited by 1
“Os estudos genéticos, principalmente de biologia molecular, têm contribuído muito para uma melhor e mais ampla compreensão da doença, tornando disponíveis técnicas precisas e eficientes de diagnóstico e tratamento precoce((1-4,9)).”
BackgroundMendes-dos-Santos, C. T., de Lemos‐Marini, S. H. V., Baptista, M. T. M., Guerra‐Júnior, G., de Mello, M. P., & Morcillo, A. M. (2009) · Revista Brasileira de Saúde Materno Infantil · doi:10.1590/s1519-38292009000400005 · Cited by 1
Krenc, Z. (2014) · Pediatria i Medycyna Rodzinna · doi:10.15557/pimr.2014.0007
Het fysiek, sociaal en maatschappelijk functioneren van kinderen met AGS en hun ouders.
Sanches, S. A., & Wiegers, T. A. (2010) · Data Archiving and Networked Services (DANS)
male CAH, salt losing crisis, 17 Hydroxy-Progesterone (17- OH P)
Sunil, B., Sahana, G. N., Adarsh, E., Purushotham, D. R., & Rajanish, K. V. (2013)
Gomes, L. G. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2009.tde-09122009-152831
Pituitary and Adrenal Disease in Pregnancy
Molitch, M. E., & Peaceman, A. M. (2010) · doi:10.1002/9781444323016.ch13
Kırmızıbekmez, H., Mutlu, R. G. Y., Moralıoğlu, S., Tellioğlu, A., & Celayir, A. C. (2015) · Case Reports in Pediatrics · doi:10.1155/2015/196374
Perspectives in Pediatric Pathology, Chapter 22. Testicular Involvement in Systemic Diseases
Nistal, M., Paniagua, R., González‐Peramato, P., & Reyes‐Múgica, M. (2014) · Pediatric and Developmental Pathology · doi:10.2350/14-09-1556-pb.1
“It occurs in approximately 1:10 000–1:15 000 births worldwide [53] (Figs.”
BackgroundJanin, C., Vigneron, V., Weryha, G., & Leheup, B. (2013) · Annales d Endocrinologie · doi:10.1016/j.ando.2012.10.003
“J Clin Endocrinol Metab 2006;91(3):865–9.”
InfluentialPrise en charge à l’âge adulte des patients avec un bloc en 21 hydroxylase
Christin‐Maître, S. (2013) · Médecine Nucléaire · doi:10.1016/j.mednuc.2012.11.002
Novel Therapies for Treating Short Stature with Congenital Adrenal Hyperplasia
Simpson, J. L., Hann, M., Kshetrapal, A., & New, M. I. (2011) · International Journal of Infertility & Fetal Medicine · doi:10.5005/jp-journals-10016-1017
Genetic Defects of Female Sexual Differentiation
Dessens, A. B., Cools, M., Richter-Unruh, A., Looijenga, L. H. J., Grootegoed, J. A., & Drop, S. L. S. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00101-7
Phenotype and genotype characteristics of Indonesian 21-hydroxylase deficient patients
Oswari, A. W., Tridjaja, B., Setianingsih, I., Tambunan, T., Pulungan, A. B., & Batubara, J. R. L. (2007) · Paediatrica Indonesiana · doi:10.14238/pi47.5.2007.189-95
Congenital Adrenal Hyperplasia: Diagnosis, Management, and Long Term Outcomes
Ammini, A. C. (2014) · The Endocrine Society eBooks · doi:10.1210/mtp3.9781936704835.ch6
Best Practice & Research Clinical Endocrinology & Metabolism
der Grinten, H. L. C., Otten, B. J., Stikkelbroeck, M., Sweep, F. C. G. J., & Hermus, A. R. M. M. (2009)
Aslih, N. (2014) · Reproductive System & Sexual Disorders · doi:10.4172/2161-038x.1000142
“Diagnosis must be based on the increased levels of ACTHstimulated steroid precursor(s) that accumulate above the enzymatic block, with the exception of lipoid adrenal hyperplasia (P450scc deficiency) in which almost no steroids are produced [7].”
BackgroundInfluentialLE DEFICIT CONGENITAL EN 21 HYDROXYLASE SUIVI CHEZ LA FEMME ADULTE
de Médecine, F. (2012)
The patient with endocrine disease
Laven, J. S. E. (2005) · CRC Press eBooks · doi:10.1201/b14473-7
Debates and Controversies in Genetic Steroid Disorders
Speiser, P. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00030-2
Assessment of inhibin B blood concentration in patients with congenital adrenal hyperplasia
Ziora, K. T., Borawska-Dziadek, E., Oświęcimska, J. M., Świętochowska, E., Ostrowska, Z., Kajdaniuk, D., Wikiera, B., Bieniasz, J., Noczyńska, A., Bursa, J., et al. (2016) · Pediatric Endocrinology · doi:10.18544/ep-01.15.03.1646
Diagnosis and Treatment of Congenital Adrenal Cortex Hyperplasia
胡, 啸. (2014) · Medical Diagnosis · doi:10.12677/md.2014.44009
Erkrankungen der endokrinen Drüsen inkl. Diabetes und Wachstumsstörungen
Hiort, O., Kapellen, T. M., Pfäffle, R. W., Raile, K., & Willgerodt, H. (2007) · Elsevier eBooks · doi:10.1016/b978-343723200-8.50021-4
CLINICAL MANIFESTATION OF LATE NEONATAL SEPSIS – CONTINU-OUS DIFFERENTIAL DIAGNOSTIC DILEMMA
Katavić, M., & Buljević, A. D. (2018) · Liječnički vjesnik · doi:10.26800/lv-141-5-6-21
Congenital adrenal hyperplasia: hospital based study
Alzubaidi, M. A. (2011) · Journal of the Faculty of Medicine Baghdad · doi:10.32007/jfacmedbagdad.532851
Hiperplasia congenita das supra-renais por deficiencia da 21-hidroxilase
dos Santos, C. T. M. (2007) · doi:10.47749/t/unicamp.2007.412236
(2021) · Elsevier eBooks · doi:10.1016/b978-3-437-22851-3.50032-3
Dörr, H. G., MWollmann, H. A., Hauffa, B. P., & Woelfle, J. (2020) · Vide Leaf, Hyderabad eBooks · doi:10.37247/paendo.1.2020.11
Bourcigaux, N., & Christin‐Maître, S. (2007) · EMC - AKOS - Trattato di Medicina · doi:10.1016/s1634-7358(07)70394-7
Bourcigaux, N., & Christin‐Maître, S. (2007) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(07)70638-4
Zurita‐Cruz, J. N., Villasís-Keever, M. Á., Damasio‐Santana, L., Apolinar, L. M., Ferrusca-Ceja, R., Nishimura‐Meguro, E., Rivera-Hernández, A. D. J., & Garrido-Magaña, E. P. (2018) · Gaceta Médica de México · doi:10.24875/gmm.m18000131
Oddział Pediatrii, S. W. R. Ś., Borawska-Dziadek, E., Ziora-Jakutowicz, K. N., & Warszawa, I. P. I. N. (2015) · Pediatric Endocrinology · doi:10.18544/ep-01.14.02.1558
The patient with endocrine disease
Laven, J. S. E. (2005) · CRC Press eBooks · doi:10.1201/b14473-4
Adrenal Glands - The Current Stage and New Perspectives of Diseases and Treatment
Păun, D. L., Cianci, P., & Restini, E. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102209 · Cited by 1
Tamizaje de Hiperplasia Adrenal Congénita en recién nacidos del Hospital General San Juan de Dios
Armas, K., & Lange, K. (2010) · Revista Científica · doi:10.54495/rev.cientifica.v19i2.158
Kılavuz, S., Bezen, D., Süt, N., Dilek, E., & Tütüncüler, F. (2022) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.1176227
Ly, N. H. H., Phong, N. V., Hà, N. T. V., & Tuấn, T. V. (2023) · Tạp chí Nghiên cứu Y học · doi:10.52852/tcncyh.v163i2.1208
Fernández, M. S., Sitja, M. M., González-Pinto, L. C., Arteta, E. L. H., & Sánchez, A. R. (2023) · Hormone and Metabolic Research · doi:10.1055/a-2111-6571 · Cited by 1
The history of prenatal diagnosis of congenital adrenal hyperplasia
New, M. I., & Lo, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00025-3
Ormoni steroidei surrenalici: androstenedione
D’Agostini, M., del GdS-EMM, A. N., & INCALZA, M. A. (2024) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.23736/s1825-859x.24.00258-5
Nguyen, K. N., Dang, G. T. K., Can, N. T. B., Điền, T. M., Bui, T. P., Phuong, M. N. T., Pham, H. T., Ngo, N. D., & Vu, D. C. (2025) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2448292.146
Effet de la modulation de l'équilibre calcique dans le cortex surrénalien
Fedlaoui, B. (2023) · theses.fr (ABES) · doi:10.70675/45da36b4z01fdz47d6za4b6z8663da88f35d
The role of Zearalenone in epigenetic modifications of candidate genes in Nellore heifers
Coelho, L. A. F., Barbero, R. P., Pereira, P. R. M. T., Polido, C. E. B., de Aguiar, A. C. S. R., Santos, H. A., de Mello, M. R. B., Kern, E. L., Andia, D. C., & Barbero, M. M. D. (2026) · Tropical Animal Health and Production · doi:10.1007/s11250-026-04978-y
“The CYP21A2 gene encodes cytochrome P450 21-hydroxylase, an enzyme involved in steroid hormone biosynthesis, particularly within glucocorticoid and miner-alocorticoid pathways (Forest 2004; Mizrachi et al. 2011).”
Urologic Emergencies in Children: Special Considerations
Chuang, K., & Khoury, A. (2026) · Springer eBooks · doi:10.1007/978-3-031-52619-0_10
Tizianel, I., Bovo, G., Mazzeo, P., Ceccato, F., & Barbot, M. (2026) · Frontiers in Adolescent Medicine · doi:10.3389/fradm.2026.1919128
Assessment of Physical Growth in Children with Congenital Adrenal Hyperplasia (CAH)
Czapla, Z., Niedziela, M., & Cieślik, J. J. (2008) · Repozytorium Uniwersytetu im. Adama Mickiewicza (Adam Mickiewicz University in Poznań)
Polycystic Ovary Syndrome in the Peripubertal Period
Witchel, S. F. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-499-5_13
Metadata
- Authors
- Forest, M. G.
- Affiliations
- Inserm (FR)
- Corresponding author
- Forest, M. G.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-09-23
- Volume
- 10
- Issue
- 6
- Pages
- 469-485
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2135400812
- Semantic Scholar
- 1bdf692960096ceca79298e51fbe52efbd96ea29
- Cited by
- 200
- References
- 150
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 2 · 2023: 10 · 2022: 8 · 2021: 5 · 2020: 6 · 2019: 3 · 2018: 7 · 2017: 4 · 2016: 10 · 2015: 9 · 2014: 14 · 2013: 14 · 2012: 16
- FWCI
- 0.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction Update (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, CYP21, intergenic recombination, genotype-phenotype correlation, salt wasting, adrenal insufficiency, precocious pubarche, polycystic ovary syndrome, glucocorticoid replacement therapy, mineralocorticoid replacement, prenatal diagnosis, newborn screening, overtreatment
- MeSH terms
- Adrenal Hyperplasia, Congenital, Body Height, Dose-Response Relationship, Drug, Female, Fertility, Genetic Counseling, Glucocorticoids, Heterozygote, Humans, Infant, Newborn, Mineralocorticoids, Mutation, Pregnancy, Prenatal Diagnosis, Steroid 21-Hydroxylase, Obstetric Surgical Procedures, Incidence, Neonatal Screening, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review